DK1959988T3 - Anvendelse af bovint lactoferrin til behandling af destruktiv inflammation af slimhinder - Google Patents

Anvendelse af bovint lactoferrin til behandling af destruktiv inflammation af slimhinder

Info

Publication number
DK1959988T3
DK1959988T3 DK06724054.9T DK06724054T DK1959988T3 DK 1959988 T3 DK1959988 T3 DK 1959988T3 DK 06724054 T DK06724054 T DK 06724054T DK 1959988 T3 DK1959988 T3 DK 1959988T3
Authority
DK
Denmark
Prior art keywords
mucosa
treatment
bovine lactoferrin
destructive inflammation
destructive
Prior art date
Application number
DK06724054.9T
Other languages
English (en)
Inventor
Piera Valenti
Rosalba Paesano
Original Assignee
Microbo Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36950064&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1959988(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Microbo Srl filed Critical Microbo Srl
Application granted granted Critical
Publication of DK1959988T3 publication Critical patent/DK1959988T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK06724054.9T 2005-12-09 2006-04-05 Anvendelse af bovint lactoferrin til behandling af destruktiv inflammation af slimhinder DK1959988T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002351A ITMI20052351A1 (it) 2005-12-09 2005-12-09 Nuovo uso farmaceutico delle transferrine e composizioni farmaceutiche derivate
PCT/EP2006/003106 WO2007065482A1 (en) 2005-12-09 2006-04-05 Use of transferrins for treating destructive inflammation of mucous membrane

Publications (1)

Publication Number Publication Date
DK1959988T3 true DK1959988T3 (da) 2012-09-10

Family

ID=36950064

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06724054.9T DK1959988T3 (da) 2005-12-09 2006-04-05 Anvendelse af bovint lactoferrin til behandling af destruktiv inflammation af slimhinder

Country Status (8)

Country Link
US (1) US9050323B2 (da)
EP (1) EP1959988B2 (da)
CN (1) CN101325965B (da)
DK (1) DK1959988T3 (da)
ES (1) ES2394344T5 (da)
IT (1) ITMI20052351A1 (da)
PL (1) PL1959988T3 (da)
WO (1) WO2007065482A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010532808A (ja) 2007-07-12 2010-10-14 ビーエーエスエフ ソシエタス・ヨーロピア パーライトフレークを基礎とする干渉顔料
SI2189062T1 (sl) * 2008-11-25 2013-11-29 Indena S.P.A. Rastlinski ekstrakti za uporabo kot fitokemikalije
PT2418945T (pt) 2009-04-15 2019-03-04 Bmg Pharma S P A Composições de sal mineral-ácido sulfónico e métodos de utilização
EP2560678A4 (en) * 2010-04-23 2013-09-18 Probiotec Ltd PHARMACEUTICAL COMPOSITIONS
IT1406153B1 (it) 2010-12-23 2014-02-14 Microbo Srl Metodi di prevenzione e terapia per parti e nascite pretermine.
CN103160565A (zh) * 2011-12-09 2013-06-19 彩虹天健康科技研究(北京)有限责任公司 Unc-51激酶影响细胞运铁蛋白的胞吞作用
CN102766206A (zh) * 2012-07-02 2012-11-07 北京济福霖生物技术有限公司 一种改善缺铁性贫血的产品及其制备方法
FR2994657A1 (fr) 2012-08-23 2014-02-28 Henri Allain Nouvelles applications et utilisations de la lactoferrine
CN103550760A (zh) * 2013-11-07 2014-02-05 无锡科捷诺生物科技有限责任公司 乳铁蛋白在制备炎症因子偏高肥胖人群贫血药物中的应用
US10172786B2 (en) * 2014-12-16 2019-01-08 Axim Biotechnologies, Inc. Oral care composition comprising cannabinoids
CN106310234A (zh) * 2016-08-24 2017-01-11 方雅悯 一种牛乳铁蛋白及水解或酶解物在治疗妇科疾病药物中的应用
CN106377768A (zh) * 2016-08-24 2017-02-08 方雅悯 一种慢性咽炎膜剂及其制备方法
RU2625739C1 (ru) * 2016-09-28 2017-07-18 Общество с ограниченной ответственностью Научно-производственное предприятие "Эксорб" Фармакологическая композиция на основе соединений железа
IT201700002411A1 (it) * 2017-01-11 2018-07-11 Bmg Pharma S R L Preparazione farmaceutica per il trattamento dell’ipoferremia e dell’anemia sideropenica
IT201900004599A1 (it) * 2019-03-27 2020-09-27 Microbo Srl Formulazioni topiche orali e/o orali sistemiche contenenti una miscela a base di lattoferrina, più efficace nella captazione del ferro, per la prevenzione e trattamento di varie patologie
CN111166872A (zh) * 2020-02-24 2020-05-19 中国科学院昆明动物研究所 转铁蛋白在制备免疫抑制剂类药物中的应用
IT202000022420A1 (it) * 2020-09-23 2022-03-23 Microbo Srl Formulazioni per somministrazioni topiche mucosali e/o orali sistemiche contenenti una miscela a base di lattoferrina, più efficace nella captazione del ferro, per la prevenzione e trattamento di varie patologie

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198419A (en) * 1989-12-08 1993-03-30 Immuno Japan Inc. Formulated medicines for enhancing the efficacy of beta-lactam antibiotics in prophylaxis and treatment against infectious disease due to pathogenic bacteria
US6066469A (en) 1990-03-08 2000-05-23 Ferro Dynamics, Inc. Cloning, expression, and uses of human lactoferrin
DE69322896T2 (de) 1992-03-02 1999-05-27 Japan Immuno Inc Verwendung von Proteinen der Transferrin/Lactoferrin-Familie zur Stimulation des Immunsystems
JPH06145068A (ja) * 1992-04-02 1994-05-24 Imuno Japan:Kk 生体防御能賦活剤・感染症治療剤・生体防御能賦活性食品
JPH08217693A (ja) 1995-02-17 1996-08-27 Yoshihisa Naito 新規医薬組成物
US20020016289A1 (en) 1995-06-01 2002-02-07 Orla M. Conneely Methods for treatment and prevention of helicobacter pylori infection using lactoferrin
US5834424A (en) 1995-07-12 1998-11-10 Gambit International Limited Use of lactoferrin for therapy of acute of chronic infectious diseases by the intracellular gram-positive pathogens streptococcus pyogenes and staphylococcus aureus
IT1278137B1 (it) * 1995-07-12 1997-11-17 Piera Valenti Utilizzo della lattoferrina per la terapia topica delle infezioni acute o recidivanti causate da "streptococcus pyogenes" o da altri
US5869446A (en) * 1996-07-09 1999-02-09 Gambit International Limited Preparation of lactoferrin (or serotransferrin or ovotransferrin) and desferrioxamine methanesulfonate (or other low molecular weight metal ion chelators) for the therapy of viral infections
WO1998033509A2 (en) † 1997-02-03 1998-08-06 Pharming Intellectual Property Bv Useful properties of human lactoferrin and variants thereof
AU7368198A (en) † 1997-05-03 1998-11-27 Board Of Regents, The University Of Texas System Methods for preventing and treating the insult-induced metabolic imbalance in humans and other animals
US6188915B1 (en) † 1998-05-19 2001-02-13 Harris Corporation Bootstrapped, piecewise-asymptotic directivity pattern control mechanism setting weighting coefficients of phased array antenna
EP1068871A1 (en) * 1999-07-07 2001-01-17 Jean-Paul Perraudin Novel methods and medicament for treating infections diseases involving microbial biofilms
WO2001072322A2 (en) * 2000-03-27 2001-10-04 Pharming Intellectual Property B.V. High dosage parenteral administration of lactoferrin
JP4683740B2 (ja) 2001-02-15 2011-05-18 明治乳業株式会社 炎症に伴う症状の軽減剤
DE10215315A1 (de) 2002-04-05 2003-11-20 Aventis Behring Gmbh Intellect Human-Transferrin zur Behandlung der Anaemia of Chronic Disease (ACD) und des funktionellen Eisenmangels
US7238661B2 (en) * 2002-05-24 2007-07-03 Agennix, Inc. Oral lactoferrin in the treatment of respiratory disorders
WO2004050037A2 (en) 2002-12-04 2004-06-17 Agennix Incorporated Lactoferrin in the reduction of circulating cholesterol, vascular inflammation, atherosclerosis and cardiovascular disease
JP4795021B2 (ja) 2002-12-06 2011-10-19 エイジェニックス インコーポレイテッド 敗血症治療における経口用ラクトフェリン
WO2005018542A2 (en) † 2003-07-10 2005-03-03 Agennix Incorporated Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects

Also Published As

Publication number Publication date
EP1959988A1 (en) 2008-08-27
CN101325965B (zh) 2012-09-12
US20090156484A1 (en) 2009-06-18
EP1959988B2 (en) 2016-03-09
ES2394344T5 (es) 2016-05-05
US9050323B2 (en) 2015-06-09
EP1959988B1 (en) 2012-05-23
PL1959988T3 (pl) 2012-11-30
ITMI20052351A1 (it) 2007-06-10
CN101325965A (zh) 2008-12-17
ES2394344T3 (es) 2013-01-30
WO2007065482A1 (en) 2007-06-14

Similar Documents

Publication Publication Date Title
DK1959988T3 (da) Anvendelse af bovint lactoferrin til behandling af destruktiv inflammation af slimhinder
DK1888033T3 (da) Fremgangsmåde og sammensætning til behandling af inflammatoriske sygdomme
CY2016029I1 (el) Πρωτεϊνες συνδεσης αντιγονου προς προπρωτεϊνη κονβερτασης σουμπτιλισινης κεχιν τυπου 9(pcsk9)
DK1951866T3 (da) Delta-9-elongaser og anvendelse heraf til fremstilling af flerumættede fedtsyrer
DK1874781T3 (da) Dihydrothienopyrimidiner til behandling af inflammatoriske sygdomme
DK2139517T3 (da) Kombination af blys inhibering og mycophenolat-mofetil til behandling af autoimmunsygdomme
DK2474321T3 (da) Sammensætninger til behandling af collagenmedierede sygdomme
DK1685834T3 (da) Anvendelse af pinolensyre til behandling af obesitet
CY2016017I2 (el) Συνθεση για θεραπεια πνευμονικης υπερτασης
DK2124999T3 (da) Activin-actrii antagonister og anvendelser til behandling af anæmi
DK2120604T3 (da) Fremgangsmåde til fraktionering af havre, produkter derved opnået, og anvendelser deraf
DK2137537T3 (da) Sammensætninger og anvendelser til behandling af multipel sklerose
DK1877232T3 (da) Fremgangsmåde til behandling af træoverflader
DK1868579T3 (da) Farmaceutisk sammensætning omfattende en omega-carboxyaryl sunstitueret diphenylurea til behandling af cancer
DK2214677T3 (da) Sammensætninger til behandling af inflammation i mavetarmkanalen
DK1948176T3 (da) Diarylurinstoffer til behandling af pulmonær hypertension
DK3424932T3 (da) Bronophthalider til terapeutisk anvendelse
DK1755661T3 (da) Gelsolin til anvendelse til behandling af infektioner
DK1928438T3 (da) Anvendelse af ibudilast til behandling af stofafhængighed
DK3403657T3 (da) Anvendelse af oligouronater til behandling af slimhyperviskositet
DK2445912T3 (da) Ny forbindelse anvendelig til behandlingen af degenerative og inflammatoriske sygdomme
DK3279663T3 (da) Anvendelse af gelsolin til diagnosticering og behandling af inflammationssygdomme
DK1896077T3 (da) Fremgangsmåder og sammensætninger til forebyggelse og behandling af inflammatoriske sygdomme
DK2063881T3 (da) Sammensætning og fremgangsmåde til virksom og sikker administration af halopyruvat til behandlingen af cancer
DK1871380T3 (da) Kombineret anvendelse af prostaglandinforbindelse og protonpumpeinhibitor til behandlingen af gastrointestinale lidelser